CRISPR/Cas9-Mediated Diacylglycerol Kinase Knockout Potentiates Anti-Tumor Efficacy of Human Chimeric Antigen Receptor T-Cells

被引：0
|
作者：
Jung, In-Young
Kim, Yoon-Young
Yu, Ho-Sung
Kim, Seokjoong
Thon, Jonathan N.
Lee, Jungmin
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3182
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Nanobody-based chimeric antigen receptor T cells designed by CRISPR/Cas9 technology for solid tumor immunotherapy
    Fengzhen Mo
    Siliang Duan
    Xiaobing Jiang
    Xiaomei Yang
    Xiaoqiong Hou
    Wei Shi
    Cueva Jumbo Juan Carlos
    Aiqun Liu
    Shihua Yin
    Wu Wang
    Hua Yao
    Zihang Yu
    Zhuoran Tang
    Shenxia Xie
    Ziqiang Ding
    Xinyue Zhao
    Bruce D. Hammock
    Xiaoling Lu
    Signal Transduction and Targeted Therapy, 6
  • [22] Efficient Crispr/Cas9-mediated Inactivation of the Glucocorticoid Receptor for antigen-specific T-cell Immunotherapy
    Alvanou, Maria
    Kouimtzidis, Anastasios
    Koukoulias, Kyriakos
    Pantazi, Chrysoula
    Psatha, Nikoletta
    Tsiolas, Giorgios
    Spyridonidis, Alexandros
    Stamatopoulos, Kostas
    Makris, Antonios
    Anagnostopoulos, Achilles
    Yannaki, Evangelia
    Papadopoulou, Anastasia
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 266 - 267
  • [23] Enhancing the anti-tumor efficacy of chimeric antigen receptor-expressing T cells with naturally occuring plant stilbenes
    Soles, Andrea
    Richardson, Elle
    Barber, Amorette
    FASEB JOURNAL, 2019, 33
  • [24] Non-Viral Generation of Chimeric Antigen Receptor T Cells Using CRISPR-Cas9
    Piscopo, Nicole J.
    Mueller, Katherine P.
    Das, Amritava
    Saraspe, Louise
    Forsberg, Matthew
    Capitini, Christian
    Saha, Krishanu
    MOLECULAR THERAPY, 2020, 28 (04) : 145 - 146
  • [25] ROR-1 specific CAR-T cells with CRISPR/Cas9-mediated glucocorticoid receptor knockout exert potent antitumor efficacy in advanced adrenocortical carcinoma
    Schauer, M. P.
    Altieri, B.
    Redondo-Frutos, R.
    Spieler, P.
    Maier, T.
    Oppelt, D.
    Kroiss, M.
    Sbiera, S.
    Weber, J.
    Fassnacht, M.
    Landwehr, L. S.
    Hudecek, M.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A203 - A203
  • [26] Anti-Tumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma
    Kakarla, Sunitha
    Chow, Kevin
    Mata, Melinda
    Song, Xiao-Tong
    Wu, Men-Feng
    Liu, Hao
    Wang, Lisa
    Rowley, David
    Pfizenmaier, Klaus
    Gottschalk, Stephen
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S348 - S349
  • [27] Blockade of protein kinase A (PKA) localization augments the trafficking and anti-tumor efficacy of adoptively transferred chimeric antigen receptor-expressing T cells
    Newick, Kheng
    O'Brien, Shaun
    Sun, Jing
    Kapoor, Veena
    Maceyko, Steve
    Lo, Albert
    Pure, Ellen
    Moon, Ed K.
    Albelda, Steven M.
    CANCER RESEARCH, 2016, 76
  • [28] CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells
    Raoud Marayati
    Laura L. Stafman
    Adele P. Williams
    Laura V. Bownes
    Colin H. Quinn
    Hooper R. Markert
    Juliet L. Easlick
    Jerry E. Stewart
    David K. Crossman
    Elizabeth Mroczek-Musulman
    Elizabeth A. Beierle
    Cancer Gene Therapy, 2022, 29 : 558 - 572
  • [29] Efficient CRISPR/Cas9-Mediated Versatile, Predictable, and Donor-Free Gene Knockout in Human Pluripotent Stem Cells
    Liu, Zhongliang
    Hui, Yi
    Shi, Lei
    Chen, Zhenyu
    Xu, Xiangjie
    Chi, Liankai
    Fan, Beibei
    Fang, Yujiang
    Liu, Yang
    Ma, Lin
    Wang, Yiran
    Xiao, Lei
    Zhang, Quanbin
    Jin, Guohua
    Liu, Ling
    Zhang, Xiaoqing
    STEM CELL REPORTS, 2016, 7 (03): : 496 - 507
  • [30] CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells
    Marayati, Raoud
    Stafman, Laura L.
    Williams, Adele P.
    Bownes, Laura V.
    Quinn, Colin H.
    Markert, Hooper R.
    Easlick, Juliet L.
    Stewart, Jerry E.
    Crossman, David K.
    Mroczek-Musulman, Elizabeth
    Beierle, Elizabeth A.
    CANCER GENE THERAPY, 2022, 29 (05) : 558 - 572
12345